1.0
Dec 19, 2022
Current employee, more than 1 year
Manchester, England
Recommend
CEO approval
Business outlook
Pros
A fantastic core of people working passionately towards the treatment of cancer therapies.
Cons
The Executives decided to axe the fantastic core of people working passionately towards the treatment of cancer therapies.